Voss Capital, LLC - IN8BIO INC ownership

IN8BIO INC's ticker is and the CUSIP is 45674E109. A total of 14 filers reported holding IN8BIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Voss Capital, LLC ownership history of IN8BIO INC
ValueSharesWeighting
Q3 2023$532,048
-24.5%
511,584
+11.7%
0.07%
-21.2%
Q2 2023$705,129
+60.5%
457,876
+35.5%
0.08%
+49.1%
Q1 2023$439,424
-43.7%
338,0190.0%0.06%
-62.5%
Q4 2022$780,824
+2.9%
338,019
-10.0%
0.15%
-30.0%
Q3 2022$759,000
-33.6%
375,570
-25.7%
0.22%
-41.5%
Q2 2022$1,143,000
+30.6%
505,635
+95.2%
0.37%
+34.9%
Q1 2022$875,000
+96.2%
259,003
+154.5%
0.28%
+99.3%
Q4 2021$446,000
-19.6%
101,779
+26.1%
0.14%
-39.5%
Q3 2021$555,00080,7270.23%
Other shareholders
IN8BIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
Voss Capital, LLC 80,727$555,0000.23%
B. Riley Financial, Inc. 257,378$1,763,0000.22%
Nantahala Capital Management 375,000$2,569,0000.08%
Rock Creek Group, LP 42,279$292,0000.05%
TUDOR INVESTMENT CORP ET AL 63,287$434,0000.01%
Tower Research Capital LLC (TRC) 2,899$20,0000.00%
Capital World Investors 800,000$5,520,0000.00%
MILLENNIUM MANAGEMENT LLC 25,340$175,0000.00%
MORGAN STANLEY 200$1,0000.00%
BlackRock Inc. 9,311$64,0000.00%
View complete list of IN8BIO INC shareholders